I have been in regular contact with my counterpart in Quebec, Rémi Quirion, as well as the chief public health officers, and I've had direct conversations with them based on the science.
As was mentioned, in terms of the question about the first and second doses, I think there was never a question that the second dose would not be given. It was the delay.
We're seeing some studies coming out of Israel where they have vaccinated a large part of their population with the Pfizer vaccine. We have to be careful. It's not the same with all vaccines. The adenovirus phase and the RNA are very different. The studies show a partial response of between 50% and 70% with the Pfizer vaccine. The second dose is far more effective.
Until we have proper clinical trials carried out using acceptable standards of consent that have gone through ethics boards, I think we should stick with the clinical studies that were carried out.